$AX

Garrabrants Gregory sold (to issuer) $10.6M of AX

Garrabrants Gregory (President and CEO) sold (to issuer) 108,995 shares of Axos Financial, Inc. (AX) at $97.39 ($10.62M total) on 2026-06-30.

Original reporting
SEC EDGAR · Garrabrants Gregory
Published Jul 1, 2026, 10:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 10:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AX
Neutral
high confidence
Mentioned
$AX
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXNeutralLow
01

Why it matters

The CEO sold shares to the issuer for ~$10.6M at a stated price; there is no accompanying guidance, earnings, legal, or regulatory development in the text.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure is unlikely to drive a major repricing without additional company-specific catalysts.

03

What to watch

The transaction is coded as a sale to the issuer (often buyback participation), which can reduce the signal-to-noise versus open-market selling.

Relevance 7/10Novelty 5/10Timing: filed after-hours on 2026-07-01; reflects 2026-06-30 transaction

Background

The article is an SEC Form 4 insider transaction disclosure for Axos Financial, Inc. (AX).

Company-level read

Ticker impact

$AXNeutralHigh confidence
Context

Axos Financial CEO Garrabrants Gregory sold 108,995 shares to the issuer for about $10.6M at $97.39/share, per Form 4.

Expected impact

Likely limited near-term impact; any effect is more about signaling/flow optics than company fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and no accompanying operational/regulatory news; such sales typically have muted price reaction unless unusually large or tied to distress (not indicated here).

Market effects

No direct sector read-through; insider sale alone doesn’t change bank/financial sector fundamentals.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted as discretionary selling rather than planned diversification, which some traders may view as mildly negative.

Key entities

  • Axos Financial, Inc.

    Subject of the Form 4 insider transaction; CEO sold shares to the issuer.

  • Garrabrants Gregory

    President and CEO; reported sale of 108,995 shares to the issuer on 2026-06-30.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXMed

Axos Target Rises to $120 on Growth Above Peers

Axos Financial (NYSE:AX) rose 1.67% after Benchmark raised its price target to $120 from $115 and kept a Buy rating. Benchmark cited a higher multiple, 12.8x its 2027 EPS estimate. It said Axos’s loan growth, profitability, and tangible book value accretion stand out. Axos reported Q4 diluted EPS $2.53 vs $2.16 expected, revenue $379.77M vs $376.59M.

$AXMed

Axos Financial (AX) Q4 2025 Earnings Call Transcript

Axos Financial (NYSE:AX) reported Q4 ended June 30, 2025 results on an earnings call. Net loan growth was $856 million, net interest margin 4.84%, net interest income $280 million, deposits $20.8 billion, and net income $110.7 million. Adjusted diluted EPS was $1.87. Management projected mid-to-high single digits to low teens loan growth for fiscal 2026 and cited a lower CA tax rate starting Sept 2025.

$AXMed

Axos Financial (AX) Q4 2025 Earnings Call Transcript

Axos Financial (AX) reported Q4 ended June 30, 2025 net loan growth of $856 million and net interest margin of 4.84%. Net interest income rose to $280 million and net income was $110.7 million. Deposits were $20.8 billion. Adjusted diluted EPS was $1.87. Management projected mid-to-high single digits to low teens loan growth for fiscal 2026 and cited a 26% to 27% future tax rate.

$AXMed

Axos Financial (AX) Q4 2025 Earnings Call Transcript

Thursday, July 30, 2025 at 5:00 p.m. ET CALL PARTICIPANTS SVP, corporate development and IR - Johnny Y. Lai President and Chief Executive Officer - Gregory Garrabrants Executive Vice President, and Chief Financial Officer - Derrick Walsh TAKEAWAYS Net Loan Growth -- $856 million for the quarter ended June 30, 2025, driven by originations in asset-based lending, commercial real estate specialty, and equipment leasing.

$AXMedAI 8/10

Axos Financial Q4 Results: Net Income Rises 12.9% To $124.9 Million

Axos Financial (NYSE: AX) reported Q4 FY26 net income of $124.9 million, up 12.9% from $110.7 million a year earlier. Diluted EPS rose to $2.16 from $1.92, and non-GAAP adjusted EPS increased to $2.53 from $1.94. Net interest income grew 13.5% to $317.9 million and non-interest income rose 49.9% to $61.9 million, with assets up 20.9% to $30.0 billion.

$AXMedAI 9/10

[AX Q4 2026 Earnings Call] Axos Financial EPS Soars 28% on Fees and Loan Surge; $2.4B Pipeline Signals More Growth — BigGo Finance

Axos Financial (AX) reported fiscal Q4 2026 adjusted diluted EPS of $2.46, up 28%, driven by loan growth, higher non-interest income from Verdant prepayment penalties, and expense control. Reported net income was $124.9M ($2.16/share) including a $21M legal accrual. Loans grew, deposits rose to $24.6B, and management cited a $2.4B loan pipeline and integration progress from acquisitions.